Evidence map›Paper›PMID 35807490›Full record

ArticleMolecules (Basel, Switzerland)2022

Periodic Mesoporous Organosilica Nanoparticles for CO

Paul Kirren, Lucile Barka, Saher Rahmani, Nicolas Bondon, Nicolas Donzel, Philippe Trens, Aurélie Bessière, Laurence Raehm, Clarence Charnay, Jean-Olivier Durand

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Tailored Carbon Nanocomposites for Efficient COMolecules (Basel, Switzerland) · 2025
    Article
  2. COMaterials (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul KirrenCapgemini Engineering, 75017 Paris, France.
Lucile BarkaCapgemini Engineering, 75017 Paris, France.
Saher RahmaniCapgemini Engineering, 75017 Paris, France.
Nicolas BondonICGM, Univ Montpellier, CNRS, ENSCM, 34293 Montpellier, France.
Nicolas DonzelICGM, Univ Montpellier, CNRS, ENSCM, 34293 Montpellier, France.
Philippe TrensICGM, Univ Montpellier, CNRS, ENSCM, 34293 Montpellier, France.ORCID 0000-0001-9162-8263
Aurélie BessièreICGM, Univ Montpellier, CNRS, ENSCM, 34293 Montpellier, France.ORCID 0000-0003-0082-546X
Laurence RaehmICGM, Univ Montpellier, CNRS, ENSCM, 34293 Montpellier, France.
Clarence CharnayICGM, Univ Montpellier, CNRS, ENSCM, 34293 Montpellier, France.ORCID 0000-0002-8796-3701
Jean-Olivier DurandICGM, Univ Montpellier, CNRS, ENSCM, 34293 Montpellier, France.ORCID 0000-0003-4606-2576

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Due to human activities, greenhouse gas (GHG) concentrations in the atmosphere are constantly rising, causing the greenhouse effect. Among GHGs, carbon dioxide (CO

Indexed as

Carbon DioxideNanoparticlesAdsorptionAminopyridinesHumansPorosityTemperatureAminopyridinesCarbon Dioxidecarbon capture and storage (CCS) applicationCO2 adsorptionperiodic mesoporous organosilicasol-gel process

Identifiers

PMID35807490
PMCPMC9268279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.